Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

Posted by on Feb 7th, 2025

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of CALA stock opened at $0.00 on Tuesday. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Read More

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.